Aims-To compare the localisation of mRNAs for the basement membrane degrading enzyme gelatinase A (72 kilodalton type IV collagenase) and its inhibitor TIMP-2 in carcinomas of the breast and basal cell carcinomas of the skin which have little or no ability to metastasise. Methods-In situ hybridisation was performed on formalin fixed, paraffin wax embedded blocks using 35S-labelled riboprobes on 16 mammary carcinomas, three fibroadenomas, and a benign phyllodes tumour, and on 15 basal cell carcinomas of the skin (BCC). Results-Labelling for both mRNAs was detectable in 14 of 16 mammary carcinomas and in 13 of 15 BCC, most often over organising desmoplastic fibroblasts in the stroma around invasive epithelial aggregates. Some sparse labelling was seen over malignant epithelial cells in six of the mammary carcinomas but not in the BCC. Some expression of gelatinase A mRNA was also seen in fibroblasts of breast lobules adjacent to the mammary carcinomas and around engulfed adnexal elements in the BCC, but not in unaffected breast tissues, fibroadenomas, the phyllodes tumour or unaffected skin. Conclusions-Maximal expression of gelatinase A and TIMP-2 mRNAs occurs in malignant neoplasms as part of the host response to the presence of established neoplastic cells rather than as an initial response to invasion. The degree to which this is present suggests this may be a highly relevant mechanism modulating tumour differentiation, growth and progression, possibly entailing uptake via specific receptors on the tumour cell surface. (7 Clin Pathol 1993;46:429-436) Invasion and metastasis is a multistage process in which the degradation of the extracellular matrix (ECM) surrounding the tumour is one essential step in allowing neoplastic cells to spread,'-3 and in particular to penetrate basement membranes which limit both the epithelial and vascular compartments. It is well known that loss of basement membrane integrity in colorectal and mammary carcinomas is associated with increased potential for metastasis and poor prognosis, although it is not clear whether this is due to reduced rate of basement membrane formation or increased turnover.45 In contrast to other malignant tumours, basal cell carcinomas (BCC) of the skin generally have a well formed basement membrane and rarely display metastatic behaviour, but the reasons for their slow clinical growth rate and indolent behaviour are unknown.68
three fibroadenomas, and a benign phyllodes tumour, and on 15 basal cell carcinomas of the skin (BCC). Results-Labelling for both mRNAs was detectable in 14 of 16 mammary carcinomas and in 13 of 15 BCC, most often over organising desmoplastic fibroblasts in the stroma around invasive epithelial aggregates. Some sparse labelling was seen over malignant epithelial cells in six of the mammary carcinomas but not in the BCC. Some expression of gelatinase A mRNA was also seen in fibroblasts of breast lobules adjacent to the mammary carcinomas and around engulfed adnexal elements in the BCC, but not in unaffected breast tissues, fibroadenomas, the phyllodes tumour or unaffected skin. Conclusions-Maximal expression of gelatinase A and TIMP-2 mRNAs occurs in malignant neoplasms as part of the host response to the presence of established neoplastic cells rather than as an initial response to invasion. The degree to which this is present suggests this may be a highly relevant mechanism modulating tumour differentiation, growth and progression, possibly entailing uptake via specific receptors on the tumour cell surface. (7 Clin Pathol 1993; 46:429-436) Invasion and metastasis is a multistage process in which the degradation of the extracellular matrix (ECM) surrounding the tumour is one essential step in allowing neoplastic cells to spread,'-3 and in particular to penetrate basement membranes which limit both the epithelial and vascular compartments. It is well known that loss of basement membrane integrity in colorectal and mammary carcinomas is associated with increased potential for metastasis and poor prognosis, although it is not clear whether this is due to reduced rate of basement membrane formation or increased turnover. 45 In contrast to other malignant tumours, basal cell carcinomas (BCC) of the skin generally have a well formed basement membrane and rarely display metastatic behaviour, but the reasons for their slow clinical growth rate and indolent behaviour are unknown. 68 One group of enzymes which show major changes in neoplasia, and which seem to be directly or indirectly implicated in many of the functional changes observed in neoplastic progression are the matrix metalloproteinases, a family of enzymes that degrade ECM proteins.9 Their functional activity is finely controlled by tissue inhibitors (TIMP and TIMP-2).'0"1 The cellular source of the ECM degrading enzymes has important implications in our understanding of tumour biology and tissue remodelling.'2 Interstitial collagenases degrade types I, II, and III collagens and are largely a product of stimulated fibroblasts"3 and some tumour cell lines.'4 '5 Stromelysin 1 and 92 kilodalton Type IV collagenase degrade basement membrane components and interstitial collagens, although they do not seem to be specifically upregulated in malignant tumours.'6 17 On the other hand, Stromelysin 3 seems to be expressed specifically in the stromal cells of malignant breast tumours. 18 In relation to neoplasia, synthesis of gelatinase A (72 kilodalton Type IV collagenase/MMP 2) correlates with invasive and metastatic capacity in experimental systems in vitro and in vivo.3 This is of particular relevance because gelatinase A specifically cleaves type IV collagenous structure of the basement membrane'9 as well as having degradative activity towards other ECM components such as fibronectin and interstitial collagenase. This is a property not shared by other metalloproteinase enzymes apart from the 92 kilodalton type IV collagen (gelatinase B) which does not show such a striking association with malignant transformation of epithelial cells and seems to be largely a product of macrophages and neutrophils.9 Further support for this is the demonstration that transfected cell lines with enhanced gelatinase A synthesis are associated with a metastatic phenotype.20 21 Thus gelatinase A is a major determinant of basement membrane degradation and vascular penetration seen in carcinomas, being synthesised in a pro-form and then activated by an as yet undetermined mechanism in vivo, involving the loss of 80 AA from the amino terminal end.22 TIMP-2 binds specifically and non-covalently to the pro-form of the 72 kilodalton Type IV collagenase in a 1:1 ratio inhibiting its enzymatic activity,23 whereas TIMP seems to inhibit most of the interstitial collagenases24 and the 92 kilodalton Type IV collagenase. 25 30 were based on those of Senior et al (1989) ," for formalin fixed, paraffin wax embedded tissue. Autoradiography was at 4°C for 11 to 35. days, after which time sections were developed in Kodak Dl 9, then counterstained by the Giemsa method. The template used for making the MMP-2 riboprobe was BamHI linearised pIV-l 627; this produced about 1 kilobase of probe complementary to about 190 bases of the C-terminal coding region and the entire 3'-untranslated region. The template for TIMP-2 riboprobe was Eco RI-linearised pSS3823 which produced about 0-8 kilobase of probe complementary to the 3'-untranslated region and extended as far as base 334 in the human TIMP-2 cDNA sequence (HSTIMP-2) (gift of W Stetler-Stevenson, NIH).
As a further control for the presence of mRNA in all compartments of the tissue, adjacent sections were hybridised with a riboprobe to detect fi actin mRNA, generated with SP6 RNA polymerase and Dra I linearised phflA-10, prepared by subcloning the 450 base pair Eco RI-Rsa I 3'-untranslated region of human f, actin present in flHF3 '-ut32 into the Eco RI-Eco RV sites of pSP73 (Promega).
The regions of sequence used to produce riboprobes were selected carefully to avoid stretches of sequence that might crosshybridise. The program ALIGN33 within the Intelligenetics package was used to assess the similarity of the chosen probe region of MMP-2 with sequences that received high scores in a "fastdb" search for related sequences, namely-collagenase (MMP-1, HSCOLLR); 92 
HUMOGCA).
To assess labelling, a minimum of 50 grains per cell above "background" or negative controls was taken, a level which we have previously found to be reproducible. Further evidence for the specificity of the hybridisation signals obtained is provided by the noticeable differences in the intensity of labelling above different tissue compartments by the three riboprobes.
Serial sections were stained using the ABC immunoperoxidase method for the following: (a) endothelial cells were identified with Q Bend 10 at 1 in 20 primary dilution; (b) macrophages were localised with rabbit polyclonal anti-lysozyme at 1 in 100 primary dilution; (c) basement membranes were identified by anti-type IV collagen (ICN-Flow, Dagenham) at 1 in 25 primary dilution. All reagents for immunohistochemistry were obtained from Dako UK unless otherwise stated.
Results

MAMMARY CARCINOMAS
Gelatinase A Labelling for MMP-2 mRNA was seen in 14 of the 16 carcinomas, predominantly in the stroma. Two unlabelled tumours also showed very weak, actin labelling, which may be a reflection of generalised mRNA degradation. In IDC there was intense focal labelling over desmoplastic fibroblasts around the larger epithelial islands (fig 1) , but not in the distribution of endothelial cells or macrophages, as judged by morphology and immunostained cells immediately adjacent to the glandular islands, with less abundant and more sporadic distribution further away. Deep in the elastotic scarring areas of the carcinomas, however, no labelling was seen over the residual fibroblast population.
In ILC, there was a more evenly distributed pattern of labelling, in keeping with the distribution and cellularity of the desmoplastic stromal cells (fig 3) . Again, there was little expression seen at the periphery of the tumour.
. A few labelled cells were seen in the stromal reaction around the pure DCIS (fig 4) and in four of the IDC which had an identifiable in situ component, but this was considerably less than that associated with the invasive areas, even allowing for differences in cellularity. There was also focal labelling of fibroblasts in non-neoplastic intralobular stroma immediately adjacent to the carcinomas (fig 5) , but not in the lobules well away from the tumours (those of more than 0 5 cm). No labelling was seen in either the fibroadenomas or the phyllodes tumour, the latter finding being slightly surprising given the degree of cellularity of the stroma.
Examination of the sections stained for type IV collagen showed that reactivity was poor or absent in high grade IDC, all of the ILC, and in one invasive tubular-cribriform carcinoma. There seemed to be a greater level of labelling overall in the more poorly differentiated tumours, but no clear relation could be established, at least at the topographic level, between the presence or absence of type IV collagen immunoreactivity and the relative abundance of gelatinase A mRNA in the corresponding areas. Very little labelling was seen over neoplastic epithelial cells, although a slight excess of grains was seen on some of the grade III IDC and on one of the ILC with solid areas. In none of these cases did the epithelial labelling exceed that seen in the stroma.
TIMP-2
In general, the labelling density and pattern of TIMP-2 mRNA followed that for gelati- nase A except that a greater number of cells appeared labelled, with a more even distribution of the grains (fig 6) . Because there are inevitable differences in penetration qualities of the two probes, it is difficult to establish any quantitative relation between TIMP-2 and gelatinase A mRNAs. No labelling of epithelial cells was observed.
BASAL CELL CARCINOMAS
Gelatinase A There was moderate to strong labelling of the stromal fibroblasts of the BCC, sometimes to an equivalent degree to that observed in the mammary carcinomas, but generally of a more patchy distribution. Strongest labelling was seen in the stroma around the larger islands of nodular BCC ( fig 7A) , with a more scattered pattern in the sclerosing areas and subtypes, similar to that seen in the stroma of the ILC. As in the mammary carcinomas, the most abundant labelling was found in the central areas rather than at the lateral and deeper invasive fronts. Examination of the sections stained for endothelial cells and macrophages showed no correlation with the mRNA labelling patterns. Interestingly, little labelling was seen over the stromal cells of the non-neoplastic skin at the margins of the excisions, but under the hyperplastic epidermis and adjacent to entrapped or engulfed adnexal elements, such as hair follicles, in stroma adjacent to non-neoplastic epithelium, the stromal fibroblasts were labelled ( fig 7B) . No labelling of the neoplastic epithelial cells was observed in any of the BCC. As in the mammary carcinomas, there was no apparent relation between basement membrane immunoreactivity and expression of gelatinase A, as immunoreactive type IV collagen was present around most of the malignant cellular aggregates.
TIMP-2
Four of the 15 BCC showed no detectable labelling using our strict criteria. In the remainder, all of which showed moderate to strong labelling for gelatinase A mRNA, there was stromal expression for TIMP-2 in the corresponding areas but again this showed a more diffuse pattern (figs 8A and B). No labelling of epithelial or endothelial cells was seen.
CONTROLS ,B actin
There was abundant expression of fi actin mRNA in both epithelial and stromal compartments of mammary carcinomas and BCC in all cases. The degree of labelling was variable, and in two mammary carcinomas and two BCC it was relatively weak, and all of these cases failed to show any expression of gelatinase A or TIMP-2. There was intense labelling of the malignant cells in both mammary carcinomas and BCC, and to a considerably greater degree than non-neoplastic epithelial and stromal cells in the same sections. The fact that appropriate labelling was obtained in a pattern different to that of both gelatinase A and TIMP-2 indicated that the probes were producing specific labelling which was not a consequence of non-specific binding of 35S-labelled riboprobes on these tissues. The only non-specific binding consistently observed was to cornified keratin in epidemis and hair follicles with all of the probes described here. Necrotic regions were invariably unlabelled and sharply delineated from the "viable" areas, also a useful sign of specific labelling.
Discussion
Invasion and metastasis involve complex interaction with the extracellular matrix, AN which is constantly being remodelled as growth and progression of the tumour continues. The highest level of extracellular matrix organisation, the basement membrane, is attenuated partly by reduced synthesis, but also by accelerated degradation. This in turn leads to reduced differentiation of the neoplastic cells, as they interact with a more primitive matrix environment, predominantly via cell surface transmembrane receptors of the integrin and non-integrin types, which control cytoskeletal organisation.'s'6 In malignant progression these receptors are also selectively up-or down-regulated, further contributing to the reduction of a stable differentiated phenotype in favour of the undifferentiated destabilised (in cytoskeletal terms) which characterises the malignant cell. '7'8 There is abundant experimental evidence that enhanced ability to degrade type IV collagen is critically involved in invasion and metastasis, perhaps as part of a more complex cascade of ECM degrading activity. [1] [2] [3] In human tumours immunolocalisation of the enzyme (including its pro-form) with wellcharacterised antibodies shows that there is increased immunoreactivity in the neoplastic cells in colorectal and mammary carcinomas,2829 although there may be a minority of cells in the stroma which are also immunoreactive,28 and this seems to support the observation that there is substantial increase in gelatinase A mRNA in colorectal carcinomas, as determined by total mRNA extraction and northern analysis.27
Thus our present finding that mRNAs for both gelatinase A and its inhibitor TIMP-2 are predominantly expressed in desmoplastic fibroblasts seems paradoxical. Nevertheless, this does not necessarily contradict the hypothesis of their role in malignant progression, and may provide some explanations of other experimental observations. It has already been shown that stromal localisation also occurs in colorectal and skin cancers, with little or no epithelial localisation. Pyke et al (1992) speculated that the same stromal localisation would not be found in cancers other than those arising in the skin,26 but our findings reported here and earlier show that this is not the case. 28 An interesting observation is that BCC (very slow growing tumours with invasive capacity but little or no metastatic potential) show similar stromal expression of gelatinase A and TIMP-2 to mammary carcinomas. This suggest that the stromal expression may not be the primary mechanism underlying deregulation of growth, differentiation, and vascular invasion. Barsky et al (1987) also localised the enzyme to the neoplastic cells of BCC, but interestingly only in the desmoplastic (sclerosing) variants and not the superficial spreading or nodular type. '9 It is difficult to hypothesise why no little or no epithelial expression is seen using in situ hybridisation, but we are convinced this is not a result of artefact, as it is observed using both the gelatinase A and TIMP-2 probes whose sequences are quite different, and it has been observed in other tumours using different probes with appropriate controls.2628 The ,B actin probe also showed appropriate and heavy labelling of both the epithelial and mesenchymal cellular constituents of the tumours, indicating that the mRNA is detectable in these cells. There is no doubt that the enzyme is present on or in the neoplastic cells of mammary and colorectal carcinomas. 28 29 The enzyme could be taken up by the malignant cells, as can be demonstrated in vitro,40 and there are some in vivo data in support of this in that immunoreactivity for gelatinase A has been reported in the lumen of rough endoplasmic reticulum of desmoplastic fibroblasts, but present as amorphous aggregates in the cytosol of neoplastic cells, implying that the fibroblasts were synthesising the enzyme and the malignant cells were taking it up.41 There is additional evidence that breast adenocarcinoma cell lines in vitro express a high affinity cell surface receptor for gelatinase A.42 It would also seem unlikely that the mRNA in the desmoplastic fibroblasts persists in an untranslated pool, and so it is a more attractive hypothesis that the enzyme is secreted more actively by the fibroblasts, either contributing to a marginal imbalance in the ratio of proteinase to inhibitor, or resulting in accumulation in the malignant cells, and available for release and activation in the immediate vicinity of the membrane. In fact, massive release and activation of the enzyme could result in widespread lysis of ECM which would inhibit the cell progress and indeed viability, by inhibiting certain matrix interactions and preventing locomotion.' If this hypothesis is correct, it may also provide an explanation for the relative paucity of labelling over the malignant cells, because the levels of mRNA in the malignant cell may not be sufficiently high to reach the threshold of detection by in situ hybridisation. Similar considerations may apply to the observation that Stromelysin 3 mRNA is present exclusively in the stroma of mammary carcinomas, judging by in situ hybridisation. 18 The mechanisms leading to the considerable increase in gelatinase A and TIMP-2 mRNAs in the desmoplastic fibroblasts are complex. It is known, however, that TGFfl will upregulate gelatinase A in fibroblasts4344 and that TGFP is abundant in the stroma of both BCC and mammary carcinomas.4546 Other growth factors and cytokines, such as TNFa and interleukins, are also potential mechanisms because they are known to influence metalloproteinase synthesis. 18 47 48 Production of a soluble factor would explain why some localisation of the mRNA was also seen around entrapped non-neoplastic elements or in tissues immediately adjacent to the tumours, as in the case of expression in the intralobular stroma of the normal breast lobule.
The consequences of this stromal expression of gelatinase A and TIMP-2 are not understood, but it seems to be a host response to 
